Dr. Sall is a regulatory strategist with over 20 years of experience, guiding clients through assessing, developing, and implementing successful global approval plans for both small molecule and biologic therapeutics. His projects range from assisting start-up biotechs in clinical trial development to conducting due diligence reviews and crafting regulatory strategies for specialty pharma companies.

His expertise spans various therapeutic areas, including dermatology, infectious disease, and pain management. Equipped with a background in pharmacy and pharmacology, he leverages his scientific background to provide innovative regulatory pathways, strategic guidance, and effective communication with Health Authorities. From academia to healthcare consultancy, Dr. Sall’s experience encompasses diverse sectors of the pharmaceutical industry, ensuring comprehensive support for clients worldwide, including North America, Europe, Asia, and Australia.

Dr. Sall received his PhD in Pharmacology from Wayne State University with three post-doctoral research training positions in neurology, neurosurgery, and ophthalmology; and PharmD from Nova Southeastern University.